(S)-haloxyfop | 95977-27-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S)-haloxyfop
• 英文别名: (-)-Haloxyfop；(2S)-2-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]propanoic acid
• CAS: 95977-27-8
• 化学式: C₁₅H₁₁ClF₃NO₄
• 分子量: 361.705
• InChiKey: GOCUAJYOYBLQRH-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  68.6
• 氢给体数：
  1
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  吡氟氯禾灵 在 甲酸铵 作用下， 以 甲醇 为溶剂， 生成 高效氟吡甲禾灵 、 (S)-haloxyfop
  参考文献：
  名称：

  评价万古霉素结合到核-壳颗粒上的埃德曼降解产物，作为新的HPLC手性固定相。

  摘要：

  通过对万古霉素的Edman降解制备的修饰的基于大环糖肽的手性固定相（CSP）被首次评估为手性选择剂。将其适用性与其他基于大环糖肽的CSP（TeicoShell和VancoShell）进行了比较。此外，还进一步检查了另一种基于大环糖肽的修饰CSP NicoShell。最初的评估集中在与这些糖肽的互补行为上。根据以前的工作，使用了一种筛选方法，用于对50种手性化合物的对映体分离，其中包括氨基酸，农药，兴奋剂和多种药物。使用表面多孔（核-壳）颗粒载体可实现快速有效的手性分离。总体，万古霉素埃德曼降解产物（EDP）与TeicoShell类似，在极性离子模式下对酸性化合物具有高对映选择性。使用液相色谱-质谱联用EDP同时分离5种外消旋脯氨酸的对映异构体，时间约为3分钟。其他亮点包括同时用VancoShell液相色谱分离rac-amphetamine和rac-methamphetamine，用Nico

  DOI：

  10.1002/chir.22985

文献信息

• HERBICIDE COMBINATION COMPRISING DIMETHOSXYTRIAZINYL-SUBSTITUTED DIFLUOROMETHANESULFONYLANILIDES
  申请人：Hacker Erwin

  公开号：US20100075854A1

  公开（公告）日：2010-03-25

  The present invention relates to a herbicide combination comprising components (A) and (B) where (A) denotes one or more compounds or salts thereof from the group described by the general formula (I): in which R 1 is halogen, preferably fluorine or chlorine, R 2 is hydrogen and R 3 is hydroxyl or R 2 and R 3 together with the carbon atom to which they are attached are a carbonyl group C═O and R 4 is hydrogen or methyl; and (B) denotes one or more herbicides from the group of the phenyl ethers consisting of: (B1-1) acifluorfen, (B1-2) aclonifen, (B1-3) fluoroglycofen, (B1-4) fomesafen, (B1-5) lactofen, (B1-6) oxyfluorfen, (B2-1) bifenox, (B2-2) HC-252 (ethoxyfen-ethyl), (B3-1) clomeprop, (B4-1) cloprop, (B4-2) dichlorprop, (B4-3) dichlorprop-P, (B4-4) mecoprop, (B4-5) mecoprop-P, (B5-1) 4-CPA, (B5-2) 2,4-D, (B5-3) MCPA, (B5-4) MCPA-thioethyl, (B6-1) 2,4-DB, (B6-2) MCPB, (B7-1) clodinafop, (B7-2) cyhalofop, (B7-3) diclofop, (B7-4) fenoxaprop-P(-ethyl), (B7-5) fluazifop, (B7-6) fluazifop-P, (B7-7) haloxyfop, (B7-8) haloxyfop-P, (B7-9) metamifop, (B7-10) propaquizafop, (B7-11) quizalofop, (B7-12) quizalofop-P.
• HERBICIDAL COMPOSITIONS COMPRISING OXYFLUORFEN AND HALOXYFOP
  申请人：Dow AgroSciences LLC

  公开号：US20140323298A1

  公开（公告）日：2014-10-30

  An herbicidal composition containing (a) oxyfluorfen and (b) haloxyfop or an agriculturally acceptable ester or salt thereof provides control of undesirable vegetation, e.g., in crops, including but not limited to direct-seeded, water-seeded and transplanted rice, wheat, barley, oats, rye, sorghum, corn/maize, cotton, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, including, but not limited to, citrus, grapes and tree nuts, aquatics, vegetables (e.g., onions, shallots, peppers, tomatoes, artichokes, cole crops, guava, papaya and strawberries), industrial vegetation management, deciduous trees, conifers, perennial crops and plantation crops (including, but not limited to, coffee and palm oil) and rights of way.
• IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS
  申请人：CAMP4 THERAPEUTICS CORPORATION

  公开号：US20210254056A1

  公开（公告）日：2021-08-19

  The present invention provides methods and compositions for the evaluation, alteration and/or optimization of gene signaling. Methods and systems are also provided which exploit the information generated in the identification of new targets and non-canonical signaling pathways.
• US5258521A
  申请人：——

  公开号：US5258521A

  公开（公告）日：1993-11-02
• Evaluation of the Edman degradation product of vancomycin bonded to core-shell particles as a new HPLC chiral stationary phase
  作者：Garrett Hellinghausen、Diego A. Lopez、Jauh T. Lee、Yadi Wang、Choyce A. Weatherly、Abiud E. Portillo、Alain Berthod、Daniel W. Armstrong

  DOI：10.1002/chir.22985

  日期：2018.9

  macrocyclic glycopeptide‐based chiral stationary phase (CSP), prepared via Edman degradation of vancomycin, was evaluated as a chiral selector for the first time. Its applicability was compared with other macrocyclic glycopeptide‐based CSPs: TeicoShell and VancoShell. In addition, another modified macrocyclic glycopeptide‐based CSP, NicoShell, was further examined. Initial evaluation was focused on the complementary

  通过对万古霉素的Edman降解制备的修饰的基于大环糖肽的手性固定相（CSP）被首次评估为手性选择剂。将其适用性与其他基于大环糖肽的CSP（TeicoShell和VancoShell）进行了比较。此外，还进一步检查了另一种基于大环糖肽的修饰CSP NicoShell。最初的评估集中在与这些糖肽的互补行为上。根据以前的工作，使用了一种筛选方法，用于对50种手性化合物的对映体分离，其中包括氨基酸，农药，兴奋剂和多种药物。使用表面多孔（核-壳）颗粒载体可实现快速有效的手性分离。总体，万古霉素埃德曼降解产物（EDP）与TeicoShell类似，在极性离子模式下对酸性化合物具有高对映选择性。使用液相色谱-质谱联用EDP同时分离5种外消旋脯氨酸的对映异构体，时间约为3分钟。其他亮点包括同时用VancoShell液相色谱分离rac-amphetamine和rac-methamphetamine，用Nico